glp 1 agonists and sglt2 inhibitors combination Combining glucagon-like peptide-1 receptor (GLP-1RAs) sodium-glucose cotransporter-2 (SGLT2is) in patients with type 2 diabetes mellitus (T2DM) | Cardiovascular Diabetology Metabolic and cardiovascular benefits with

*Correspondence: Jixin Zhong, [email protected]

GLP-1 receptor agonists work by mimicking the incretin hormone glucagon-like peptide-1, which enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety

[22] Vilsbll T, et al

Patients now have access to a GLP-1 therapy option that eliminates needles

Several segments in the ECD of GCGR, the stalk between ECD and transmembrane helix 1 (TM1) of GLP-1R (residues 130135), extracellular loop 1 (ECL1) of GIPR (residues 202207), and intracellular loop 3 (ICL3) of GLP-1R and GIPR (residues 338343 and 330333, respectively) were poorly resolved and not modeled in the structures